Advertisement

Topics

Pharmalink AB Company Profile

16:23 EST 21st November 2017 | BioPortfolio

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical product development and the excellence of medical science in Sweden to identify and progress products that address significant unmet medical needs. Pharmalink has introduced more than 15 pharmaceutical products to the market. Using a repurposing and reformulation strategy, Pharmalink minimizes the risk of product development. The Company's strategy is to develop drugs to clinical proof-of-concept and then to out-license or divest to a commercial partner. Pharmalink currently has two clinical phase development projects, Nefecon(R) and BusulipoTM, mature for out-licensing to a commercial partner and is actively in-licensing promising new projects to add to its pipeline. Visit http://www.pharmalink.se for further information.


News Articles [8 Associated News Articles listed on BioPortfolio]

New CFO for Pharmalink

Thomas Eklund New Chairman of Pharmalink AB

  Life Sciences Jobs   ...

Pharmalink AB Strengthens Its Management Team. Appoints New Chief Financial Officer And Head Of Communications

  Life Sciences Jobs   ...

Thomas Eklund New Chairman of Pharmalink

STOCKHOLM, August 24, 2017 /PRNewswire/ -- The Swedish specialty pharmaceutical company Pharmalink AB today announced the appointment of Thomas Eklund as new Chairman of the board. Thoma...

Pfizer Upbeat After Bagging Besponsa Approval in US

It is the first CD22-directed antibody-drug conjugate indicated for relapsed or refractory B-cell precursor acute lymphoblastic leukemia, though sales potential...  

Deal Watch: WuXi/Gloria License PD-1 Inhibitor To Arcus For Up To $816m

WuXi Biologics and Harbin Gloria will get $18.5m up front for the Phase I asset GLS-010. Also, Cerecor divests depression...   

Appointments: Novo Nordisk, Horizon Pharma, Jounce Therapeutics, Pfenex and Pharmalink

This week's roundup includes CEO appointments by ProTA and Pfenex with various other high-level appointments by Novo Nordisk, Jounce Therapeutics...   

Pharmalink AB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryPharmalink AB Pharmalink is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company's product pipeline includes Nefecon ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Pharmalink AB

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical product development and the ex...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based o...

More Information about "Pharmalink AB" on BioPortfolio

We have published hundreds of Pharmalink AB news stories on BioPortfolio along with dozens of Pharmalink AB Clinical Trials and PubMed Articles about Pharmalink AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmalink AB Companies in our database. You can also find out about relevant Pharmalink AB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record